Skip to main content
Inside Vol VI: 3M announces $7.35B AFFF settlement, Bard PowerPort surges +406 cases, FDA orders NAION vision-loss warnings on all GLP-1 drugs, litigation funding disclosure in Georgia, autonomous vehicle liability, and the AI verification layer for PI paralegals.
Happy Thanksgiving from Draft n Craft
Draft n Craft Smart Paralegal Solutions · Since 2008

The Personal Injury Wire

3M’s $7.35B AFFF settlement, Bard PowerPort surges +406 cases, FDA orders NAION vision-loss warnings across all GLP-1 drugs, litigation funding disclosure in Georgia, and the AI verification layer every PI paralegal must check.

Vol VI · November 2026
01

In the Spotlight

3M’s $7.35 Billion AFFF Settlement: What PFAS Personal Injury Lawyers Need to Know

For years, the AFFF personal injury litigation has been marked by a significant gap: thousands of claimants, but no jury verdict. On November 3, 2026, 3M announced a historic settlement intended to resolve most PFAS-related personal injury claims in MDL No. 2873 — covering approximately 99% of current personal injury claims and potentially 115,000 to 120,000 plaintiffs. The $7.35 billion nominal commitment, structured across nine years, represents one of the largest toxic tort resolutions in modern legal history.

Read the full story →
02

Mass Tort MDL Watch

Mass Tort MDL Tracker — October 2026

Source: U.S. Judicial Panel on Multidistrict Litigation · Report date: October 1, 2026

Mass Tort MDL Tracker — October 2026 Chart
Roundup pending actions fell by 2,821 in October (3,925 to 1,104), a net reduction shown as -2,821 and plotted at zero.
Paraquat shed 64 cases in October (shown as -64).
Monthly change = pending actions on the October 1, 2026 JPML report minus the September 1, 2026 report.
The Headline Number
Bard PowerPort added +406 cases (4,140 total), after a flat September. That follows the $40 million Divelbliss verdict and the third bellwether trial starting October 13.
Hair Relaxer
Added +252 cases (12,381 total), the second-largest gain, after +350 in September.
Suboxone
Jumped +195 cases (2,022 total), a jump after two flat months.
J&J Talcum Powder
Added +90 cases (69,340 total), a slowdown from +336 in September.
New Cases Added in October 2026
Net change in pending actions
Bard PowerPort +406
AFFF Hair Relaxer +252
Suboxone +195
J&J Talcum Powder +90
Paragard IUD +39
Depo-Provera +9
Bard Hernia Mesh +8
GLP-1 / Ozempic +3
Paraquat -64
Roundup -2,821
Total Active Cases (Oct 1, 2026)
Cumulative docket volume
J&J Talcum Powder 69,340
Bard Hernia Mesh 23,324
AFFF Hair Relaxer 12,381
Paraquat 6,602
Depo-Provera 6,412
Paragard IUD 4,224
Bard PowerPort 4,140
GLP-1 / Ozempic 4,025
Suboxone 2,022
Roundup 1,104

Docket Commentary:

  • Bard PowerPort added +406 (4,140 total), after a flat September. That follows the $40 million Divelbliss verdict and the third bellwether trial starting October 13.
  • Hair Relaxer added +252 (12,381 total), the second-largest gain, after +350 in September.
  • Suboxone added +195 (2,022 total), a jump after two flat months.
  • J&J Talcum Powder added +90 (69,340 total), a slowdown from +336 in September.
  • Depo-Provera added only +9 (6,412 total), and GLP-1 only +3 (4,025 total).
  • Paraquat shed 64 cases (6,602 total).
03

Law & Order

FDA Orders NAION Warning on All GLP-1 Drugs: What It Means for the Ozempic Vision-Loss Lawsuits

The FDA has officially directed manufacturers of all GLP-1 receptor agonists — including Ozempic, Wegovy, Mounjaro, and Zepbound — to update their prescribing labels to include warnings about NAION (non-arteritic anterior ischemic optic neuropathy), an irreversible condition often called an “eye stroke.”

This regulatory shift fundamentally strengthens the failure-to-warn theories advanced in the GLP-1 multidistrict litigation. While defendants continue to assert preemption and dispute general causation, the agency’s uniform mandate creates powerful contemporaneous evidence of knowable risk.

Read the full story →
04

The Deep Dive

Litigation Funding Disclosure Laws: What Georgia’s SB 69 Requires and How Other States Compare

Georgia has joined a fast-growing wave of jurisdictions mandating disclosure of third-party litigation funding agreements. Under SB 69, plaintiffs must disclose the existence of third-party financing arrangements, creating new compliance obligations and strategic considerations during early discovery.

This comprehensive analysis breaks down Georgia's specific requirements, compares them against evolving statutory frameworks in Wisconsin, Montana, and Indiana, and outlines proactive protocol adjustments plaintiff firms must implement to protect work product while satisfying disclosure mandates.

Read the full story →
05

The Tech Brief

Who Do You Sue When the Car Drives Itself? Autonomous Vehicle Liability After a $243 Million Verdict

A landmark $243 million verdict against an autonomous vehicle manufacturer has upended conventional automotive products liability litigation. When an algorithm — rather than a human driver — makes the split-second decisions leading to impact, every element of duty, breach, and causation shifts into complex software diagnostics.

This feature explores the emerging legal theories governing sensor suite failures, over-the-air firmware updates, and the strict evidentiary thresholds required to preserve Event Data Recorder (EDR) telemetry before it is overwritten.

Read the full story →
06

Mark Your Calendars

Dec
2
The Ritz-Carlton, New Orleans, LA
Dec
9
NYC Bar Association, New York, NY
07

The Paralegal Docket

The AI Verification Layer: What Every PI Paralegal Should Check Before a Filing Reaches Counsel

As litigation teams increasingly integrate generative AI into deposition summarization, medical indexing, and draft pleadings, the paralegal’s quality-control checkpoint has become the ultimate defense against hallucinated citations, misattributed record pages, and evidentiary spoliation.

This practical checklist outlines five non-negotiable verification gates every personal injury paralegal must execute before permitting AI-assisted work product onto an attorney's desk.

Read the full story →
08

From the DNC Desk

Gaps Found Early Get Fixed. Gaps Found at the Deadline Don’t.

In personal injury and mass tort litigation, case strength isn’t decided when opening statements begin. It’s decided months earlier — when thousands of pages of medical records, treatment timelines, and billing entries are meticulously sorted and cross-examined.

Draft n Craft provides turnkey medical records chronologies, demand package preparation, and specialized paralegal support so your trial lawyers can focus on winning verdicts.

From our team to yours, wishing you a season of gratitude. Happy Thanksgiving from all of us at Draft n Craft

Don't let bandwidth be the reason good cases get bad outcomes.

Draft n Craft QR Code